Company Filing History:

11 out of 318

Taiho Pharmaceutical Company Limited

patents

3 out of 138

Otsuka Kagaku Kabushiki Kaisha

patents

1 out of 14

Delta-fly Pharma, Inc.

patents

4. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1985-2014

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8889699 - 5-fluorouracil derivative (2014-11-18),

2. 6818764 - Process for preparing substance GM-95 (2004-11-16),

3. 6248768 - Benzimidazole derivatives and pharmacologically acceptable salts thereof (2001-06-19),

4. 6110967 - Epoxysuccinamide derivative or salt thereof (2000-08-29),

5. 5786355 - 4,6-diarylpyrimidine derivatives and salts thereof (1998-07-28),

6. 5728841 - Process for preparing 1-amino-1,2,3-triazole (1998-03-17),

7. 5401739 - Benzothiadiazine derivatives (1995-03-28),

8. 4933444 - Process for preparing 2.beta.-substituted-methylpenicillin derivatives (1990-06-12),

9. 4898939 - Process for preparing 2.beta.-substituted-methylpenicillin derivatives (1990-02-06),

10. 4895941 - Process for preparing (1990-01-23),

11. 4891369 - 2.beta.-Substituted-methylpenicillanic acid derivatives, and salts and (1990-01-02),

12. 4861768 - 2 .beta.-substituted thiomethylpenicillin derivatives and their (1989-08-29),

13. 4518712 - Piperazine derivative and analgesic composition containing the same (1985-05-21),

Title: Innovator Shozo Yamada: Pioneering Anticancer Solutions

Introduction: Shozo Yamada, located in Hanno, Japan, is a distinguished inventor with an impressive portfolio of 13 patents. His work primarily focuses on innovations in the pharmaceutical sector, particularly in anticancer agents.

Latest Patents: Yamada's recent inventions include two significant contributions to cancer treatment. The first is a 5-fluorouracil derivative, which is characterized as a novel antimetabolic anticancer agent, boasting a remarkable balance between antitumor efficacy and minimized toxicity. This medicament includes an active ingredient represented by a specific chemical formula, accommodating various configurations of hydrogen atoms, protecting groups, alkoxy groups, carbon or nitrogen atoms, and halogen or cyano groups. The second patent details a Process for Preparing Substance GM-95. This innovative method involves deprotecting a macrocyclic compound by removing protective groups and forming complex ring structures through intramolecular cyclization reactions.

Career Highlights: Throughout his career, Shozo Yamada has made substantial contributions to the pharmaceutical industry, particularly during his tenure at notable companies such as Taiho Pharmaceutical Company Limited and Otsuka Pharmaceutical Co., Ltd.. These experiences have greatly informed his inventive processes and patent developments.

Collaborations: Yamada has collaborated with prominent coworkers including Motoaki Tanaka and Tetsuji Asao. Their teamwork has likely facilitated the innovative approaches reflected in Yamada's patents, combining expertise and creativity to advance pharmaceutical science.

Conclusion: In conclusion, Shozo Yamada stands out as a remarkable inventor in the field of pharmaceuticals, particularly in anticancer innovations. His work has the potential to significantly improve treatment options for cancer patients, showcasing the importance of innovation in the medical sector.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.